News
News

News

11/19/2019 STRATA Skin Sciences, Inc. Announces Compliance with Nasdaq Listing Rules

STRATA Skin Sciences, Inc. Announces Compliance with Nasdaq Listing Rules

HORSHAM, Pa. , Nov. 19, 2019 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN) (“STRATA” or the “Company”), a medical technology company in Dermatology and Plastic Surgery dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic
11/14/2019 STRATA Skin Sciences to Participate in the 13th Annual Canaccord Genuity Medical Technologies & Diagnostics Forum

STRATA Skin Sciences to Participate in the 13th Annual Canaccord Genuity Medical Technologies & Diagnostics Forum

HORSHAM, Pa. , Nov. 14, 2019 (GLOBE NEWSWIRE) -- STRATA Skin Sciences (NASDAQ: SSKN) (“STRATA”) a medical technology company in Dermatology and Plastic Surgery dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, today announced
10/07/2019 Strata Skin Sciences Receives Nasdaq Notice of Non-compliance

Strata Skin Sciences Receives Nasdaq Notice of Non-compliance

HORSHAM, Pa. , Oct. 07, 2019 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (Nasdaq: SSKN) (“STRATA” or the “Company”), a medical technology company in Dermatology and Plastic Surgery dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic
08/16/2019 STRATA Skin Sciences Receives Notice of Filing Delinquency from NASDAQ

STRATA Skin Sciences Receives Notice of Filing Delinquency from NASDAQ

HORSHAM, Pa. , Aug. 16, 2019 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN) (“STRATA” or the “Company”), a medical technology company in Dermatology and Plastic Surgery dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic
08/06/2019 STRATA Skin Sciences Announces Preliminary Second Quarter 2019 Financial Results and Updates

STRATA Skin Sciences Announces Preliminary Second Quarter 2019 Financial Results and Updates

Unaudited Second Quarter 2019 total revenue of $8.2 million increased 9% year-over-year First half total revenue of $15.6 million increased 12% year-over-year Recurring revenue of $6.0 million increased 16% year-over-year Domestic installed base increased from 754 to 764 sequentially Gross margin